178 related articles for article (PubMed ID: 10675331)
1. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.
Goi T; Shipitsin M; Lu Z; Foster DA; Klinz SG; Feig LA
EMBO J; 2000 Feb; 19(4):623-30. PubMed ID: 10675331
[TBL] [Abstract][Full Text] [Related]
2. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
3. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
4. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
Karni R; Jove R; Levitzki A
Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.
Chang JH; Wilson LK; Moyers JS; Zhang K; Parsons SJ
Oncogene; 1993 Apr; 8(4):959-67. PubMed ID: 7681161
[TBL] [Abstract][Full Text] [Related]
8. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
9. c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells.
Cirri P; Chiarugi P; Marra F; Raugei G; Camici G; Manao G; Ramponi G
Biochem Biophys Res Commun; 1997 Oct; 239(2):493-7. PubMed ID: 9344858
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.
Senga T; Iwamoto T; Kitamura T; Miyake Y; Hamaguchi M
J Biol Chem; 2001 Aug; 276(35):32678-81. PubMed ID: 11432872
[TBL] [Abstract][Full Text] [Related]
11. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
13. Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling.
Drube S; Stirnweiss J; Valkova C; Liebmann C
Cell Signal; 2006 Oct; 18(10):1633-46. PubMed ID: 16495036
[TBL] [Abstract][Full Text] [Related]
14. Role of c-Src tyrosine kinase in EGF-induced mitogenesis.
Belsches AP; Haskell MD; Parsons SJ
Front Biosci; 1997 Oct; 2():d501-18. PubMed ID: 9331427
[TBL] [Abstract][Full Text] [Related]
15. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
Soler C; Alvarez CV; Beguinot L; Carpenter G
Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
[TBL] [Abstract][Full Text] [Related]
16. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK).
Jain N; Zhang T; Fong SL; Lim CP; Cao X
Oncogene; 1998 Dec; 17(24):3157-67. PubMed ID: 9872331
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
18. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H
Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375
[TBL] [Abstract][Full Text] [Related]
19. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
Gao Y; Tang S; Zhou S; Ware JA
J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
[TBL] [Abstract][Full Text] [Related]
20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]